An updated analysis of JULIET, a global pivotal phase 2 trial of tisagenlecleucel in adult patients with replapsed or refractory (r/r) diffuse large b cell lymphoma (DLBCL) - Borchmann, P; Tam, C S; Jäger, U
EHA Library Borchmann P. 2018 Jun 16; 214521: S799. Im Internet (Stand: 05.09.2019):